We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
-6.62%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$159M
AUM Growth
-$13M
Cap. Flow
-$34.8K
Cap. Flow %
-0.02%
Top 10 Hldgs %
22.04%
Holding
189
New
40
Increased
46
Reduced
55
Closed
32

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$1.24M
2
ARW icon
Arrow Electronics
ARW
+$1.12M
3
IDXX icon
Idexx Laboratories
IDXX
+$918K
4
ROL icon
Rollins
ROL
+$908K
5
DHR icon
Danaher
DHR
+$906K

Top Sells

Rank Stock Value
1
LNG icon
Cheniere Energy
LNG
+$2.66M
2
WMT icon
Walmart Inc
WMT
+$2.1M
3
CHRW icon
C.H. Robinson
CHRW
+$1.39M
4
ABT icon
Abbott
ABT
+$1.31M
5
AME icon
Ametek
AME
+$1.26M

Sector Composition

Rank Sector Weight
1 Industrials 21.35%
2 Healthcare 19.44%
3 Financials 12.65%
4 Consumer Staples 12.28%
5 Technology 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTR icon
151
Nutrien
NTR
$37.6B
$200K 0.13%
2,400
-13,700
-85% -$1.18M
XRN
152
Chiron Real Estate Inc
XRN
$478M
$194K 0.12%
4,565
-80
-2% -$4.41K
HLN icon
153
Haleon
HLN
$40.6B
$181K 0.11%
+29,750
New +$193K
F icon
154
Ford
F
$53.8B
$127K 0.08%
+11,350
New +$159K
ALB icon
155
Albemarle
ALB
$13.4B
– –
-4,175
Closed -$872K
AME icon
156
Ametek
AME
$53.8B
– –
-11,445
Closed -$1.26M
AVT icon
157
Avnet
AVT
$7.6B
– –
-22,780
Closed -$977K
AXTA icon
158
Axalta
AXTA
$7.12B
– –
-23,425
Closed -$518K
BX icon
159
Blackstone
BX
$95.1B
– –
-6,800
Closed -$620K
CCJ icon
160
Cameco
CCJ
$39.7B
– –
-27,450
Closed -$577K
CHRW icon
161
C.H. Robinson
CHRW
$18.4B
– –
-13,675
Closed -$1.39M
CLF icon
162
Cleveland-Cliffs
CLF
$6.73B
– –
-16,175
Closed -$249K
COF icon
163
Capital One
COF
$127B
– –
-3,805
Closed -$396K
CVS icon
164
CVS Health
CVS
$121B
– –
-13,045
Closed -$1.21M
DVN icon
165
Devon Energy
DVN
$56.5B
– –
-21,382
Closed -$1.18M
ELAN icon
166
Elanco Animal Health
ELAN
$11.5B
– –
-26,400
Closed -$518K
EXPE icon
167
Expedia Group
EXPE
$35.2B
– –
-2,340
Closed -$222K
FCX icon
168
Freeport-McMoran
FCX
$99.6B
– –
-24,838
Closed -$727K
FISV
169
Fiserv Inc
FISV
$26.6B
– –
-8,601
Closed -$765K
GILD icon
170
Gilead Sciences
GILD
$181B
– –
-12,350
Closed -$763K
H icon
171
Hyatt Hotels
H
$15.1B
– –
-12,200
Closed -$902K
HPE icon
172
Hewlett Packard
HPE
$74.2B
– –
-12,650
Closed -$168K
HWM icon
173
Howmet Aerospace
HWM
$89.6B
– –
-7,250
Closed -$228K
KLAC icon
174
KLA
KLAC
$220B
– –
-28,000
Closed -$893K
KNX icon
175
Knight Transportation
KNX
$11.1B
– –
-10,495
Closed -$486K
4 5 6
7
8

Similar funds

GFP
Guardian Financial Partners Orange, California $257M AUM 19.03% 1-Year Est. Return
UI
Untitled Investments New York $257M AUM 15.31% 1-Year Est. Return
HWA
HMV Wealth Advisors Shreveport, Louisiana $257M AUM 26.62% 1-Year Est. Return
LGW
Leslie Global Wealth Itasca, Illinois $257M AUM 23.12% 1-Year Est. Return
TCG
Transcendent Capital Group Edmond, Oklahoma $257M AUM 25.68% 1-Year Est. Return
6F
626 Financial Portage, Michigan $257M AUM 22.23% 1-Year Est. Return
MCP
Miller Capital Partners Troy, Michigan $257M AUM
BWM
Birchcreek Wealth Management Miami Township, Ohio $257M AUM 34.72% 1-Year Est. Return

New England Research & Management's Q3 2022 Portfolio in Review

As of Q3 2022, New England Research & Management held 189 positions worth $159M, down 7.6% from $172M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

New England Research & Management's Q3 2022 filing shows 40 new, 46 increased, 55 reduced and 32 closed positions. Its largest new stake was United Therapeutics: 5,550 shares worth $1.16M. The largest sale was Cheniere Energy, an estimated $2.66M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • New England Research & Management's largest Q3 2022 buy was United Therapeutics: 5,550 shares worth $1.16M.
  • New England Research & Management added most to Coca-Cola in Q3 2022, an estimated $817K increase.
  • New England Research & Management's biggest Q3 2022 reduction was Walmart Inc, cutting an estimated $2.1M.
  • New England Research & Management fully exited Cheniere Energy in Q3 2022, selling an estimated $2.66M.
  • New England Research & Management's ten largest holdings make up 22% of its $159M portfolio in Q3 2022.
  • New England Research & Management opened 40 new positions and closed 32 in Q3 2022.
  • New England Research & Management's portfolio value fell 7.6% quarter-over-quarter to $159M.

Based on New England Research & Management's 13F filing for Q3 2022, filed 6 Oct 2022.